Vaccines arrive in SA, but itâs still a 2-week wait for the first jab â hereâs what happens now Feb 02, 2021, 06:43 AM
facebook
Oxford-AstraZeneca Covid-19 vaccine (Photo by Tharaka Basnayaka/NurPhoto via Getty Images)
One million Covid-19 vaccine doses, developed by AstraZeneca and supplied by India’s Serum Institute, have arrived in South Africa.
These doses are due to stay in a secure, cold-chain management facility in Johannesburg while awaiting further test results conducted by the National Control Laboratory.
Authorisation is expected to be granted between 12 and 16 February, at which time the doses will be delivered to provinces.
In the meantime, government is finalising its provincial distribution model which is likely to see the doses kept in a central vaccine centre for each province.
Cheap meat makes future pandemics likely say scientists in South Africa
71
Scientists in South Africa warn that unless we change our relationship with meat, more pandemics look increasingly likely in the future.
Our desire for cheap meat could land us in trouble in the future according to scientists.
The term “once in a generation” has been used frequently to describe the havoc being wreaked by COVID-19. Yet some scientists feel that the current pandemic, which has already infected more than 16 million people and killed more than 600,000 people worldwide, is only a dress rehearsal for an even bigger one.
The human demand for affordable meat is creating the perfect breeding ground for more diseases of this kind, scientists at the University of the Free State (UFS) in South Africa have claimed.
Keeping meat animals in conditions where they are stressed creates conditions for new viruses to form Demand for regular supplies of affordable meat will create future pandemics that will make Covid-19 pandemic look like a “dress rehearsal", scientists are warning. Producing meat is creating the perfect breeding ground for diseases of the same kind to emerge, according to the South African academics. The risk is created by humans’ interactions.
University of the Free State (UFS) clinical research company FARMOVS, together with several medical and scientific experts at the university, is in the process of preparing a clinical trial protocol to determine the efficacy of Ivermectin for treating Covid-19 in a randomised, controlled study according to the requirements of the legal professions, to submit it for approval to the relevant national regulatory authority. FARMOVS is a South African specialty full-service clinical research organisation conducting